News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,136 Results
Type
Article (39176)
Company Profile (284)
Press Release (648676)
Section
Business (203928)
Career Advice (2001)
Deals (35376)
Drug Delivery (89)
Drug Development (80852)
Employer Resources (168)
FDA (16101)
Job Trends (14813)
News (344683)
Policy (32452)
Tag
Academia (2530)
Alliances (49192)
Alzheimer's disease (1262)
Approvals (16063)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11585)
Biotechnology (201)
Breast cancer (190)
Cancer (1376)
Cardiovascular disease (110)
Career advice (1668)
Cell therapy (282)
Clinical research (64710)
Collaboration (485)
Compensation (263)
COVID-19 (2541)
C-suite (109)
Data (1394)
Diabetes (176)
Diagnostics (6170)
Earnings (84895)
Employer resources (146)
Events (110025)
Executive appointments (397)
FDA (16788)
Funding (431)
Gene therapy (195)
GLP-1 (599)
Government (4334)
Healthcare (18704)
Infectious disease (2634)
Inflammatory bowel disease (111)
Interviews (310)
IPO (16344)
Job creations (3627)
Job search strategy (1422)
Layoffs (418)
Legal (7863)
Lung cancer (198)
Manufacturing (207)
Medical device (13214)
Medtech (13219)
Mergers & acquisitions (19199)
Metabolic disorders (460)
Neuroscience (1584)
NextGen Class of 2024 (6501)
Non-profit (4470)
Northern California (1702)
Obesity (262)
Opinion (183)
Parkinson's disease (98)
Patents (120)
People (56482)
Phase I (20127)
Phase II (28499)
Phase III (21242)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5892)
Regulatory (21681)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1471)
Startups (3562)
United States (15249)
Vaccines (564)
Weight loss (182)
Date
Today (108)
Last 7 days (560)
Last 30 days (2393)
Last 365 days (35303)
2024 (35146)
2023 (40078)
2022 (51176)
2021 (55717)
2020 (54088)
2019 (46544)
2018 (35025)
2017 (32113)
2016 (31486)
2015 (37559)
2014 (31324)
2013 (26355)
2012 (28574)
2011 (29267)
2010 (27334)
Location
Africa (714)
Arizona (196)
Asia (37280)
Australia (6088)
California (3835)
Canada (1458)
China (307)
Colorado (173)
Connecticut (178)
Europe (79849)
Florida (538)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (635)
Massachusetts (2975)
Michigan (175)
Minnesota (292)
New Jersey (1108)
New York (1091)
North Carolina (743)
Northern California (1702)
Ohio (146)
Pennsylvania (929)
South America (1093)
Southern California (1471)
Texas (555)
Utah (108)
Washington State (402)
688,136 Results for "biosense webster inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO™ 3 System Version 8, the latest version of the company’s leading three-dimension heart mapping system used in cardiac ablation procedures.
May 8, 2024
·
8 min read
Biotech Beach
Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE™ Platform for the Treatment of Paroxysmal Atrial Fibrillation
Biosense Webster, Inc. announced the submission of the VARIPULSE™ Platform for Premarket Approval Application (PMA) to the U.S. Food & Drug Administration (FDA).
March 25, 2024
·
8 min read
Biotech Beach
Biosense Webster Presents Late-Breaking Data from admIRE Clinical Trial at the Heart Rhythm Society Annual Meeting
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced late-breaking results from the pivotal phase of the admIRE pivotal clinical trial, plus additional results from the VIRTUE study, presented at the Heart Rhythm Society (HRS) Annual Meeting in Boston from May 16-19.
May 17, 2024
·
12 min read
Biotech Beach
Biosense Webster Announces Regulatory Approval of VARIPULSE™ Pulsed Field Ablation (PFA) Platform in Japan
Biosense Webster, Inc. today announced approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the VARIPULSE™ Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AFib) using pulsed field ablation (PFA).
January 9, 2024
·
7 min read
Biotech Beach
Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced the U.S. launch of the OPTRELL™ Mapping Catheter with TRUEref™ Technology powered by the CARTO® 3 System.
July 24, 2023
·
8 min read
Business
Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
Gritstone bio, Inc. today announced the appointment of Stephen Webster to its Board of Directors.
April 29, 2024
·
5 min read
Biotech Beach
New Biosense Webster QDOT MICRO™ Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib Patients
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced new findings from the Q-FFICIENCY study were published in the Journal of Cardiovascular Electrophysiology demonstrating treatment with the QDOT MICRO™ Catheter significantly improved control of atrial fibrillation, relief of symptoms and overall quality of life.
November 2, 2023
·
10 min read
FDA
Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i today announced that several products in its market-leading cardiac ablation portfolio have received approval for a zero fluoroscopy workflow from the U.S. Food and Drug Administration (FDA).
August 4, 2023
·
8 min read
Biotech Beach
New Data Published on Biosense Webster QDOT MICRO™ Catheter - the Latest Advancement in Focal RF Ablation for Treating AFib
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced that data from the Q-FFICIENCY study was published in JACC: Clinical Electrophysiology.
May 15, 2023
·
9 min read
Biotech Beach
Biosense Webster, Inc. to Highlight Latest Innovations at AF Symposium 2023 Showcasing Breadth of Cardiac Rhythm Portfolio
Biosense Webster, Inc. announced that data from five company-sponsored studies, including two late breakers, will be presented at the 28th Annual International AF Symposium in Boston from February 2–4.
January 23, 2023
·
7 min read
1 of 68,814
Next